Objectives of the study are:- To investigate the difference in the nature and severity of objective visual disorders between patients with MS or PD who report visual complaints and those who do not report visual complaints.- To investigate the…
ID
Source
Brief title
Condition
- Neurological disorders NEC
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
The main study parameter is the objective visual disorders.
Secondary outcome
The secondary parameters are the results of the assessments done at Royal Dutch
Visio: standardized interviews and questionnaires, visual function assessments,
and neuropsychological/perceptual assessments of the patients with visual
complaints and a (control) group of patients without visual complaints (MS and
PD).
Background summary
Currently, there is a lack of knowledge, acknowledgement and recognition in
research and clinical practice about visual disorders in patients with multiple
sclerosis (MS) or Parkinson*s disease (PD). Patients presumably do not get
optimal care and will continue to have complaints in daily life.
Study objective
Objectives of the study are:
- To investigate the difference in the nature and severity of objective visual
disorders between patients with MS or PD who report visual complaints and those
who do not report visual complaints.
- To investigate the relationship between subjective visual complaints and
objective visual disorders of patients with MS or PD with or without visual
complaints.
- To investigate the relationship between subjective visual complaints,
objective visual disorders and cognitive functioning in patients with MS or PD
with or without visual complaints.
Study design
Cross sectional
Study burden and risks
The assessments at Royal Dutch Visio are all part of standard care of patients
with MS and PD that suffer from visual complaints. A control group of patients
without visual complaints will be asked to participate in the same assessments,
which take up to 4 hours. The assessments can require some concentration from
which a patient can recover after a short break. The risks of the study and the
burden on the patients are therefore negligible. Participants know they can
refuse or end participation in the study at any time. Traveling expenses will
be reimbursed.
Grote Kruisstraat 2/1
Groningen 9712TS
NL
Grote Kruisstraat 2/1
Groningen 9712TS
NL
Listed location countries
Age
Inclusion criteria
Patients must be diagnosed with multiple sclerosis or Parkinson's disease.
Patients must be 18 years of age or older.
Exclusion criteria
Any health condition or disease (other than multiple sclerosis or Parkinson's disease) that is likely to have significant impact on visual, motor or cognitive functioning.
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| CCMO | NL62728.042.17 |